Equipment used to support the manufacturing process is not maintained at appropriate intervals to prevent malfunctions, making the equipment unavailable for its intended use for equipment (b) (4) I Specifically, a.
Inspection Record
Fin Vector Oy — FDA 483 Findings
View the regulator's official source The source document is always the basis for judgement.
Findings
requency to confirm the (b) (41= currently has no requirements for (b) (4) Equipment used to clean drug product not adequately maintained.
The Quality System procedure for deviations and incidents allows for planned deviations to document a departure from a previously approved process as stated below: SOP - version 16, effective September 7, 2022, states in step 5.1, deviation may also be raised to document planned departure from written procedure or previously approved process.
Performance Qualification Validation and documentation required for the labelling and packaging of the filled drug product are not complete.
A record as of the US FDA document published on 2026-10-26. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.